SCHEMBL7488176

SCHEMBL7488176

CC(C)(C)[Si](Oc1cccc(CC2CCOC2=O)c1)(c1ccccc1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
KCNH3 Q9ULD8 1/20 0.36
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
HTR1A P08908 2/20 0.32
SMYD2 Q9NRG4 1/20 0.32
ROCK2 O75116 1/20 0.32
MEN1 O00255 1/20 0.32
CYP1A2 P05177 1/20 0.32
KMT2A Q03164 1/20 0.32
SLC6A4 P31645 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7491561 0.78 ALDH1A1 (0.47) ALDH1A1GAAHTR1AROCK2MEN1
SCHEMBL9029731 0.76 SMYD2 (0.43) KCNH3ALDH1A1SMYD2CYP1A2
SCHEMBL16225349 0.76 SMYD2 (0.43) KCNH3ALDH1A1SMYD2CYP1A2
SCHEMBL7906013 0.73 MAOB (0.49) KCNH3
SCHEMBL3685687 0.73 MAOB (0.49) KCNH3
SCHEMBL7899581 0.73 MAOB (0.49) KCNH3
SCHEMBL3978646 0.73 MAOA (0.35) ALDH1A1MEN1KMT2A
SCHEMBL4950223 0.71 CTBP2 (0.39) CYP1A2
SCHEMBL826279 0.69 KDM4E (0.41) KCNH3ALDH1A1GAAMEN1CYP1A2
SCHEMBL183914 0.69 KDM4E (0.41) KCNH3ALDH1A1GAAMEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0842161-B1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2002-09-18 EP disclosed
EP-1213285-A2 4,5-dipheny-oxazole derivatives and their use as platelet aggregation inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-06-12 EP disclosed
US-6300344-B1 FOR THERAPEUTIC AND/OR PROPHYLACTIC TREATMENT OF ARTERIAL OBSTRUCTION, CEREBROVASCULAR DISEASE, HEPATIC CIRRHOSIS, ARTERIOSCLEROSIS, ISCHEMIC HEART DISEASE, RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY, HYPERTENSION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-10-09 US disclosed
US-5972965-A USEFUL FOR INHIBITION OF PLATELET AGGREGATION, VASODILATION, ANTIHYPERTENSIVE ACTIVITY AND PROSTAGLANDIN AGONIST FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-10-26 US disclosed
EP-0842161-A1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-05-20 EP disclosed
WO-1997003973-A1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-02-06 WO disclosed